Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, NY

Clinical Trial Details


Research Study Summary

Prostate Cancer - Adult Men


Men with prostate cancer are asked to participate in a research study being conducted by Jacobi Medical Center.

Patient Inclusion Criteria
You may be eligible to participate in this study if you:

  • Are a male at least 18 years of age
  • Have been diagnosed with prostate cancer

Patient Exclusion Criteria
You may not participate in this study if you:

  • Have a history or evidence of central nervous system cancer or spinal cancer.
  • Have urinary tract obstruction.
  • Have a history of bilateral orchiectomy, adrenalectomy, hypophysectomy or hypogonadism.
  • Have current malignancy or history of malignancy within 5 years prior to screening with the exception of the following:
    • Prostate cancer
    • Treated basal or skin cancer
  • Allergic to leuprolide, polylactic acid
  • Have incomplete recovery from a major surgery
  • Have had the following prostate cancer therapies within 8 weeks prior to the Screening Visit:
    • Chemotherapy
    • Immunotherapy
    • Antiandrogen
    • Radiation therapy (EBRT, 3D-CRT, IMRT, PBRT or brachytherapy)
    • Cryotherapy
    • Strontium
    • Biological response modifiers
  • Have a history of prostatic surgery (includes transurethral resection of prostate [TURP] and radical prostatectomy) within 4 weeks prior to the Screening Visit
  • Have had hormonal therapy
  • Use alternative medical therapies which have an estrogenic, androgenic, or antiandrogenic effect within 12 weeks prior to the Screening Visit and through the Treatment Period
  • Have been exposed to finasteride or ketoconazole within 1 week prior to the Screening Visit and through the Treatment Period; dutasteride within 25 weeks prior to the Screening Visit and through the Treatment Period
  • Require the chronic use of systemic corticosteroids or anticonvulsants that may affect bone loss such as carbamazepine, phenobarbital, phenytoin, valproic acid or primidone
  • Consume more than 14 alcoholic beverages per week or history of alcoholism or illicit drug abuse within the 12 months prior to Screening
  • Have participated in another research study within the last 30 days

To Learn more

CW ID: 137471
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

18 and up
Overall Status
Facility Type


Maria Chiodi, Study Coordinator
Biomedical Research Alliance of New York
1400 Pelham Parkway South Building # 5, Room 230
Bronx, NY 10461
Phone: 718-918-6973
Fax: 718-918-4308

View Map

Research Center Information:

Biomedical Research Alliance of New York

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.